TrialThe international journal of neuropsychopharmacology2016

Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study.

Adam J Savitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.